216 related articles for article (PubMed ID: 24517166)
1. Circulating galectin-1 concentrations in systemic sclerosis: potential contribution to digital vasculopathy.
Yanaba K; Asano Y; Akamata K; Noda S; Aozasa N; Taniguchi T; Takahashi T; Toyama T; Ichimura Y; Sumida H; Kuwano Y; Miyazaki M; Sato S
Int J Rheum Dis; 2016 Jun; 19(6):622-7. PubMed ID: 24517166
[TBL] [Abstract][Full Text] [Related]
2. A possible contribution of elevated serum clusterin levels to the inhibition of digital ulcers and pulmonary arterial hypertension in systemic sclerosis.
Yanaba K; Asano Y; Tada Y; Sugaya M; Kadono T; Sato S
Arch Dermatol Res; 2012 Aug; 304(6):459-63. PubMed ID: 22350181
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of circulating platelet-activating factor acetylhydrolase levels in systemic sclerosis.
Yanaba K; Asano Y; Tada Y; Sugaya M; Kadono T; Sato S
Arch Dermatol Res; 2012 Apr; 304(3):203-8. PubMed ID: 22139405
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis.
Taniguchi T; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
J Rheumatol; 2012 Mar; 39(3):539-44. PubMed ID: 22247367
[TBL] [Abstract][Full Text] [Related]
5. Serum heparanase levels: A protective marker against digital ulcers in patients with systemic sclerosis.
Wu CY; Asano Y; Taniguchi T; Sato S; Yu HS
J Dermatol; 2015 Jun; 42(6):625-8. PubMed ID: 25808574
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance is associated with digital ulcer in patients with systemic sclerosis.
Park EK; Lee SG; Kim BH; Park JH; Lee S; Kim GT
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):85-91. PubMed ID: 27383539
[TBL] [Abstract][Full Text] [Related]
7. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
[TBL] [Abstract][Full Text] [Related]
8. A potential contribution of trappin-2 to the development of vasculopathy in systemic sclerosis.
Miyagawa T; Asano Y; Saigusa R; Hirabayashi M; Yamashita T; Taniguchi T; Takahashi T; Nakamura K; Miura S; Yoshizaki A; Miyagaki T; Sato S
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):753-760. PubMed ID: 30520152
[TBL] [Abstract][Full Text] [Related]
9. Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis.
Avouac J; Meune C; Ruiz B; Couraud PO; Uzan G; Boileau C; Kahan A; Chiocchia G; Allanore Y
Ann Rheum Dis; 2012 Mar; 71(3):394-9. PubMed ID: 22085793
[TBL] [Abstract][Full Text] [Related]
10. Serum level of endostatin and digital ulcers in systemic sclerosis patients.
Gigante A; Margiotta D; Navarini L; Barbano B; Gasperini ML; D'Agostino C; Amoroso A; Afeltra A; Rosato E
Int Wound J; 2018 Jun; 15(3):424-428. PubMed ID: 29600562
[TBL] [Abstract][Full Text] [Related]
11. Possible association of elevated serum collagen type IV level with skin sclerosis in systemic sclerosis.
Motegi SI; Sekiguchi A; Fujiwara C; Toki S; Ishikawa O
J Dermatol; 2017 Feb; 44(2):167-172. PubMed ID: 27568491
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of pentraxin 3 in systemic sclerosis: associations with vascular manifestations and defective vasculogenesis.
Shirai Y; Okazaki Y; Inoue Y; Tamura Y; Yasuoka H; Takeuchi T; Kuwana M
Arthritis Rheumatol; 2015 Feb; 67(2):498-507. PubMed ID: 25385504
[TBL] [Abstract][Full Text] [Related]
13. A potential contribution of psoriasin to vascular and epithelial abnormalities and inflammation in systemic sclerosis.
Takahashi T; Asano Y; Yamashita T; Nakamura K; Saigusa R; Miura S; Ichimura Y; Toyama T; Hirabayashi M; Taniguchi T; Yoshizaki A; Sato S
J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):291-297. PubMed ID: 28681537
[TBL] [Abstract][Full Text] [Related]
14. Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis.
Hebbar M; Peyrat JP; Hornez L; Hatron PY; Hachulla E; Devulder B
Arthritis Rheum; 2000 Apr; 43(4):889-93. PubMed ID: 10765935
[TBL] [Abstract][Full Text] [Related]
15. CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis.
Taniguchi T; Miyagawa T; Toyama S; Yamashita T; Nakamura K; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S; Asano Y
Exp Dermatol; 2018 Sep; 27(9):1030-1037. PubMed ID: 29947047
[TBL] [Abstract][Full Text] [Related]
16. Detection of severe digital vasculopathy in systemic sclerosis by colour Doppler sonography is associated with digital ulcers.
Lüders S; Friedrich S; Ohrndorf S; Glimm AM; Burmester GR; Riemekasten G; Backhaus M
Rheumatology (Oxford); 2017 Nov; 56(11):1865-1873. PubMed ID: 28340234
[TBL] [Abstract][Full Text] [Related]
17. Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis.
Stochmal A; Czuwara J; Zaremba M; Rudnicka L
Arch Dermatol Res; 2020 Aug; 312(6):453-458. PubMed ID: 31667578
[TBL] [Abstract][Full Text] [Related]
18. High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis.
Kowal-Bielecka O; Bielecki M; Guiducci S; Trzcinska-Butkiewicz B; Michalska-Jakubus M; Matucci-Cerinic M; Brzosko M; Krasowska D; Chyczewski L; Kowal K
Arthritis Res Ther; 2013; 15(3):R69. PubMed ID: 23800379
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of genomic DNA of α1(I) collagen are elevated in scleroderma patients.
Sawamura S; Jinnin M; Shimbara M; Nakamura K; Kudo H; Inoue K; Nakayama W; Kajihara I; Fukushima S; Ihn H
J Dermatol; 2017 Aug; 44(8):927-931. PubMed ID: 28370352
[TBL] [Abstract][Full Text] [Related]
20. Increased circulating soluble vascular adhesion protein-1 levels in systemic sclerosis: association with lower frequency and severity of interstitial lung disease.
Yanaba K; Yoshizaki A; Muroi E; Ogawa F; Shimizu K; Sato S
Int J Rheum Dis; 2013 Aug; 16(4):442-7. PubMed ID: 23992266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
